1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy, safety, and immune priming effect of tazemetostat in patients with epithelioid sarcoma
    Meeting Abstract

    Gounder, M. M.; Stacchiotti, S.; Schoffski, P.; Cote, G. M.; Villalobos, V. M.; Jahan, T. M.; Chen, T. W. W.; Ratan, R.; Gupta, A. A.; Dileo, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small cell lung cancer
    Meeting Abstract

    Goto, K.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T. M.; Gainor, J. F.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST): Analyses from INVICTUS
    Meeting Abstract

    George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G. Z.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Comprehensive breast cancer (BC) risk assessment for CHEK2 carriers incorporating a polygenic risk score (PRS) and the Tyrer-Cuzick (TC) model
    Meeting Abstract

    Gallagher, S.; Hughes, E.; Kurian, A. W.; Domchek, S. M.; Garber, J. E.; Probst, B.; Morris, B.; Tshiaba, P.; Rosenthal, E. T.; Roa, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial
    Meeting Abstract

    Garcia-Aguilar, J.; Patil, S.; Kim, J. K.; Yuval, J. B.; Thompson, H.; Verheij, F.; Lee, M.; Saltz, L. B.; on behalf of the OPRA Consortium
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients receiving neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in HER2-positive early breast cancer (BC)
    Meeting Abstract

    Ferraro, E.; Barrio, A. V.; Patil, S.; Robson, M. E.; Dang, C. T.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial
    Meeting Abstract

    Ficial, M.; Jegede, O.; Sant'Angelo, M.; Moreno, S.; Braun, D. A.; Wind-Rotolo, M.; Pignon, J. C.; Catalano, P. J.; Sun, M. X. N.; Van Allen, E. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy (chemo) in first-line metastatic non-small cell lung cancer (NSCLC): CheckMate 568 Part 2
    Meeting Abstract

    Gainor, J. F.; Schneider, J. G.; Gutierrez, M.; Orcutt, J. M.; Finley, G. G.; Otterson, G. A.; Rybkin, I. I.; Reddy, P. S.; Horn, L.; Brahmer, J. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prospective agnostic germline testing in pediatric cancer patients
    Meeting Abstract

    Fiala, E.; Kennedy, J.; Kemel, Y.; Mauguen, A.; Mandelker, D.; Zehir, A.; Birsoy, O.; Bouvier, N.; Maio, A.; Latham, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CodeBreak 100: Activity of AMG 510, a novel small molecule inhibitor of KRAS(G12C), in patients with advanced colorectal cancer
    Meeting Abstract

    Fakih, M.; Desai, J.; Kuboki, Y.; Strickler, J. H.; Price, T. J.; Durm, G. A.; Falchook, G. S.; Denlinger, C. S.; Krauss, J. C.; Shapiro, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save